Short tandem repeat profiling is the most validated method to confirm cell line identity and avoid misidentified or cross-contaminated cell lines.
Maryellen de Mars
Advertisement
Maryellen de Mars, PhD, is senior director, Standards Resource Center, ATCC.
Articles by Maryellen de Mars
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
3
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
4
After the Pivot: What In Vivo Cell Therapy Offers, and What It Still Has to Prove
5